This HTML5 document contains 142 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
skoshttp://www.w3.org/2004/02/skos/core#
rdfshttp://www.w3.org/2000/01/rdf-schema#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n8http://dx.doi.org/10.1038/
n13http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
n11https://scigraph.springernature.com/pub.10.1038/
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q48336057
rdf:type
wikibase:Item
schema:description
2013年學術文章 wetenschappelijk artikel articolo scientifico tudományos cikk научни чланак teaduslik artikkel artículu científicu 2013年学术文章 artykuł naukowy 2013年學術文章 мақолаи илмӣ vetenskaplig artikel bài báo khoa học 2013年学术文章 artigo científico scientific article published on 9 December 2013 مقالة علمية نشرت في 9 ديسمبر 2013 научная статья 2013 nî lūn-bûn artikulong pang-agham naučni članak articol științific 2013年學術文章 επιστημονικό άρθρο 2013年の論文 article scientifique 2013년 논문 2013年學術文章 article científic vědecký článek научни чланак vitskapeleg artikkel 2013年学术文章 artigo científico bilimsel makale 2013 թվականի դեկտեմբերի 9-ին հրատարակված գիտական հոդված scientific article published on 9 December 2013 სამეცნიერო სტატია scienca artikolo ৯ ডিসেম্বর ২০১৩-এ প্রকাশিত বৈজ্ঞানিক নিবন্ধ vedecký článok 2013年學術文章 artículo científico publicado en 2013 מאמר מדעי article scientific wissenschaftlicher Artikel videnskabelig artikel vitenskapelig artikkel 2013年学术文章 artigo científico tieteellinen artikkeli บทความทางวิทยาศาสตร์ artikel ilmiah наукова стаття, опублікована в грудні 2013 scientific article published on 9 December 2013 2013年学术文章 научна статия 2013年学术文章 artikull shkencor
p:P577
wds:Q48336057-F83E0220-5644-486E-8865-2332DC32E2EA
wdt:P577
2013-12-09T00:00:00Z
p:P407
wds:Q48336057-9431DEB2-A3F0-4956-8A69-B4A3325A21C8
wdt:P407
wd:Q1860
p:P2888
wds:Q48336057-6BC9478A-E78F-42DD-8135-F0918815E509
wdt:P2888
n11:bmt.2013.193
p:P2860
wds:Q48336057-8DF83F7A-3036-498F-86B8-10E9D9C0ADFC wds:Q48336057-98217162-57AC-471B-A44B-24A99446E74C wds:Q48336057-7F44B114-1353-41F3-A56E-96ECDAE63EEC wds:Q48336057-84224623-C0BD-4AFA-ABB6-5A4D18C03061 wds:Q48336057-76846FBF-DED5-473B-9A37-268849F154C1 wds:Q48336057-4DE03688-1DD5-4597-832F-4D063AE117B1 wds:Q48336057-5CB76883-9188-4201-95A0-4004EA7AFCDC wds:Q48336057-15D91A5D-B160-4E65-A1C2-61205798FCE2 wds:Q48336057-2C1E7E1F-CF3D-43C6-A364-053C774E4829 wds:Q48336057-01BB2E52-4685-4ABF-B1AE-1E11AA641E0E wds:Q48336057-B66158CB-BD5C-40E6-B4D7-78B17E303715 wds:Q48336057-D3463324-F8DD-444C-BB34-C4EBAA41FE30 wds:Q48336057-DABEF0EC-C2E1-40AA-A0EE-A5389D243F60 wds:Q48336057-9C771C1A-CB35-4862-AAEC-11A99CDDECCC wds:Q48336057-ABC79D5A-5E79-4EA7-9FD9-F98A4539AD66 wds:Q48336057-AC6F20C9-2985-4273-B719-BC5BECD166B4
wdt:P2860
wd:Q43282877 wd:Q44556507 wd:Q44221518 wd:Q33543723 wd:Q53271576 wd:Q42592824 wd:Q46052750 wd:Q56986459 wd:Q74405585 wd:Q45270392 wd:Q83049944 wd:Q31135878 wd:Q84596003 wd:Q51518039 wd:Q83098427 wd:Q51010848
p:P2093
wds:Q48336057-3DCB04E5-86C5-4E74-A895-A0B8FCBEB82D wds:Q48336057-241D68C4-54BF-44A5-9436-433F587F2807 wds:Q48336057-7EA51BEC-CBE2-4799-BE00-5255BB3F0666
wdt:P2093
L Roncari F Ravagnani P Longoni
rdfs:label
Plerixafor 'on demand': results of a strategy based on peripheral blood CD34+ cells in lymphoma patients at first or subsequent mobilization with chemotherapy+G-CSF. Plerixafor 'on demand': results of a strategy based on peripheral blood CD34+ cells in lymphoma patients at first or subsequent mobilization with chemotherapy+G-CSF.
skos:prefLabel
Plerixafor 'on demand': results of a strategy based on peripheral blood CD34+ cells in lymphoma patients at first or subsequent mobilization with chemotherapy+G-CSF. Plerixafor 'on demand': results of a strategy based on peripheral blood CD34+ cells in lymphoma patients at first or subsequent mobilization with chemotherapy+G-CSF.
schema:name
Plerixafor 'on demand': results of a strategy based on peripheral blood CD34+ cells in lymphoma patients at first or subsequent mobilization with chemotherapy+G-CSF. Plerixafor 'on demand': results of a strategy based on peripheral blood CD34+ cells in lymphoma patients at first or subsequent mobilization with chemotherapy+G-CSF.
p:P50
wds:Q48336057-F737FFEF-A2E6-4068-AB07-DA47473A1C7C wds:Q48336057-5A2F83E3-623E-48E2-B7E1-238AE5FD71D6 wds:Q48336057-6EB3F96E-A794-4DF0-934E-DC44199010BB wds:Q48336057-8122C79B-9459-4474-8A64-C6549B635D35 wds:Q48336057-9367D9ED-FE12-441B-AE05-F46AC699B5A8
wdt:P50
wd:Q37838306 wd:Q42234542 wd:Q37838318 wd:Q51010935 wd:Q51010946
p:P1476
wds:Q48336057-779662DE-CE26-424C-9FBB-7FCFCAABD22E
wdt:P1476
Plerixafor 'on demand': results of a strategy based on peripheral blood CD34+ cells in lymphoma patients at first or subsequent mobilization with chemotherapy+G-CSF.
p:P304
wds:Q48336057-72EDAC84-B0E8-46F5-84B4-2EF530E72A46
wdt:P304
453-455
p:P31
wds:Q48336057-82ADFC98-5637-4A0E-9CC4-72A8A104BAEC
wdt:P31
wd:Q13442814
p:P921
wds:Q48336057-73B6D763-D0B2-4915-BFF7-3BD0A0D39128
wdt:P921
wd:Q974135
p:P698
wds:Q48336057-0B6F099A-FA06-4E4A-B822-22AB3D6D1104
wdtn:P698
n13:24317127
wdt:P698
24317127
p:P1433
wds:Q48336057-57ED9428-0094-4917-BA1E-E9B8268C6801
wdt:P1433
wd:Q4941523
p:P433
wds:Q48336057-5D198141-23FD-4FA3-8850-A58CD0863128
p:P478
wds:Q48336057-B290BCDA-C9E6-43A4-B7A6-537D8FD36BAE
wdt:P433
3
wdt:P478
49
p:P356
wds:Q48336057-9A8B4CE9-B187-4566-8788-090AD85E608C
wdtn:P356
n8:BMT.2013.193
wdt:P356
10.1038/BMT.2013.193
p:P5875
wds:Q48336057-F41545C3-348D-43B0-AC75-966052AA3A4B
wdt:P5875
259247524